全文获取类型
收费全文 | 2694篇 |
免费 | 153篇 |
国内免费 | 1篇 |
专业分类
2848篇 |
出版年
2022年 | 10篇 |
2021年 | 34篇 |
2020年 | 19篇 |
2019年 | 21篇 |
2018年 | 19篇 |
2017年 | 26篇 |
2016年 | 45篇 |
2015年 | 63篇 |
2014年 | 90篇 |
2013年 | 192篇 |
2012年 | 139篇 |
2011年 | 167篇 |
2010年 | 100篇 |
2009年 | 80篇 |
2008年 | 147篇 |
2007年 | 147篇 |
2006年 | 145篇 |
2005年 | 157篇 |
2004年 | 136篇 |
2003年 | 137篇 |
2002年 | 158篇 |
2001年 | 49篇 |
2000年 | 37篇 |
1999年 | 57篇 |
1998年 | 44篇 |
1997年 | 28篇 |
1996年 | 32篇 |
1995年 | 24篇 |
1994年 | 38篇 |
1993年 | 27篇 |
1992年 | 23篇 |
1991年 | 39篇 |
1990年 | 28篇 |
1989年 | 28篇 |
1988年 | 31篇 |
1987年 | 27篇 |
1986年 | 22篇 |
1985年 | 21篇 |
1984年 | 20篇 |
1983年 | 25篇 |
1982年 | 18篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1979年 | 16篇 |
1978年 | 14篇 |
1976年 | 10篇 |
1975年 | 16篇 |
1974年 | 17篇 |
1973年 | 17篇 |
1971年 | 10篇 |
排序方式: 共有2848条查询结果,搜索用时 15 毫秒
21.
22.
Ichiro Tabuchi Sayaka Soramoto Miho Suzuki Koichi Nishigaki Naoto Nemoto Yuzuru Husimi 《Biological procedures online》2002,4(1):49-54
The “in vitro virus” is a molecular construct to perform evolutionary protein engineering. The “virion(=viral particle)”(mRNA-peptide fusion),
is made by bonding a nascent protein with its coding mRNA via puromycin in a test tube for in vitro translation. In this work, the puromycin-linker was attached to mRNA using the Y-ligation, which was a method of two single-strands
ligation at the end of a double-stranded stem to make a stem-loop structure. This reaction gave a yield of about 95%. We compared
the Y-ligation with two other ligation reactions and showed that the Y-ligation gave the best productivity. An efficient amplification
of the in vitro virus with this “viral genome” was demonstrated.
Published: October 28, 2002 相似文献
23.
Summary The ventral prostatic secretory epithelial cells in older rats were studied by light and electron microscopy. The cells vary in height in different parts of the same organ, and ultrastructurally they show the presence of a developed secretory apparatus such as well-developed Golgi body and abundant rough endoplasmic reticulum. They also show signs of a depressed secretory activity, involving occasional emiocytosis of apical secretory vacuoles and a paucity of condensing vacuoles in the Golgi region and above it. Further, they are characterized by the frequent occurrence of supra and paranuclear pleomorphic lysosomes. 相似文献
24.
Tadao Niijima Takashi Umeda Manabu Kuriyama Hiroyuki Ohmori Yohsuke Matsumura Tomoyasu Tsushima Toyoko Tanahashi Jun Yoshimoto Toshihiko Asahi Norimasa Ike Taiichiro Johsen Noritaka Ishido Naoki Mitsuhata Takeshi Uyama Hiroyoshi Tanaka Hideo Ueda Jisaburo Sakatoku Norio Yamamoto Kazuo Nagata Yukitoshi Fujita Masaaki Morioka Kazuo Kurokawa Susumu Kagawa Tomoyuki Ishibe Yasutoshi Himeno Toyofumi Ueda 《Cancer immunology, immunotherapy : CII》1989,30(2):81-85
Summary In order to examine its clinical efficacy, recombinant human interferon- (rIFN-) was instilled intravesically into 51 patients with superficial bladder cancer. Ten patients, who received intermittent intravesical instillation at a dose of (3–36) × 106 U rIFN- on days 1–3 every week, showed no response. Thirty-two patients received intravesical instillation at a dose of (3–36) × 106 U every day for 10–20 days. Eight patients showed partial response, indicating an efficacy rate of 25%. Nine patients received divided doses of 18 × 106 U twice a day every day for 10–20 days. Six patients showed partial response, indicating an efficacy rate of 67%. This value was significantly higher than that obtained by administering divided doses. The response to intravesical instillation therapy with rIFN- varies with treatment protocol. Frequent and longer exposure to rIFN- may induce better regression of superficial bladder cancer. Six incidences of side-effects were found in five cases (9.8%): pollakiuria in one, pain on micturition in two, fever in two, and eruption in one case. All of these side-effects were slight and reversible after drug withdrawal. Laboratory tests showed only a few changes with low severity. Thus, rIFN- is potentially a new drug for instillation therapy of superficial bladder cancer, in view of the absence of adverse effects. 相似文献
25.
26.
27.
Kazutaka Miyamoto Mizuha Akiyama Fumiya Tamura Mari Isomi Hiroyuki Yamakawa Taketaro Sadahiro Naoto Muraoka Hidenori Kojima Sho Haginiwa Shota Kurotsu Hidenori Tani Li Wang Li Qian Makoto Inoue Yoshinori Ide Junko Kurokawa Tsunehisa Yamamoto Tomohisa Seki Masaki Ieda 《Cell Stem Cell》2018,22(1):91-103.e5
28.
29.
A part of genomic DNA including the calcitonin gene-related peptide (CGRP) gene was cloned from flounder by the genome-walking method. The intron/exon boundary was predicted to occur exactly at the same position as in salmon. The 37-amino acid molecule coded by the region from the intron/exon boundary to the stop codon was preceded by a typical Lys-Arg cleavage signal and included a cleavage/amidation site common to the CGRP of other vertebrates. The predicted amino acid sequence of flounder CGRP had 78%, 78%, 78%, 81%, and 73-78% identity to that of salmon, cod, frog, chicken, and mammalian CGRPs, respectively. Among vertebrates, CGRP is more conserved than calcitonin (CT) because the identity of flounder CT to mammalian CTs is 31-50%. Expression analysis indicated that this hormone is synthesized in the brain, heart, intestine, testis, and ovary. Since we have previously shown that the CGRP receptor is expressed in these tissues, it is suggested that CGRP secreted from each tissue functions in a paracrine or autocrine manner. 相似文献
30.